CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist
  • 35.17
  • +0.35+1.01%
Market Closed May 31 15:00 CST
27.09BMarket Cap27.82P/E (TTM)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-3.19%2.09B
-0.33%8.22B
4.13%5.79B
8.31%4.09B
14.03%2.15B
19.42%8.25B
3.94%5.56B
3.69%3.77B
3.42%1.89B
4.60%6.91B
Operating revenue
-3.19%2.09B
-0.33%8.22B
4.13%5.79B
8.31%4.09B
14.03%2.15B
19.42%8.25B
3.94%5.56B
3.69%3.77B
3.42%1.89B
4.60%6.91B
Other operating revenue
----
-9.16%16.23M
----
-28.99%6.34M
----
16.58%17.87M
----
-0.40%8.92M
----
12.34%15.33M
Total operating cost
-4.42%1.72B
-1.77%7.36B
2.39%5.03B
4.56%3.47B
6.61%1.8B
19.70%7.49B
3.50%4.91B
3.17%3.32B
3.95%1.69B
3.92%6.26B
Operating cost
-8.42%1.01B
-7.09%4.6B
-2.68%3.19B
-2.13%2.17B
-3.61%1.1B
19.40%4.96B
5.81%3.28B
5.71%2.22B
8.32%1.14B
3.05%4.15B
Operating tax surcharges
7.74%22.61M
3.07%79.05M
0.33%53.02M
4.43%40.31M
19.04%20.99M
19.60%76.69M
9.18%52.85M
11.57%38.6M
6.86%17.63M
10.00%64.12M
Operating expense
-6.27%553.35M
7.98%2.13B
16.86%1.45B
24.52%1.07B
38.65%590.35M
26.52%1.97B
2.93%1.24B
2.47%855.8M
-1.33%425.79M
6.76%1.56B
Administration expense
63.26%111.49M
0.99%381.63M
-5.76%254.19M
-10.78%156.98M
-28.54%68.29M
1.25%377.89M
-13.70%269.72M
-12.70%175.94M
-5.27%95.56M
4.47%373.22M
Financial expense
116.36%688.58K
60.72%-15.62M
50.84%-16.13M
35.45%-16.82M
64.38%-4.21M
12.84%-39.77M
-39.97%-32.8M
-30.33%-26.05M
-53.51%-11.82M
-70.78%-45.63M
-Interest expense (Financial expense)
-15.17%6.83M
249.15%35.85M
626.10%27.83M
975.31%17M
--8.06M
249.61%10.27M
30.49%3.83M
--1.58M
----
44,000.67%2.94M
-Interest Income (Financial expense)
44.03%-6.88M
2.64%-54.64M
-15.17%-46.03M
-21.10%-35.73M
6.05%-12.29M
-11.18%-56.12M
-50.42%-39.97M
-48.75%-29.51M
-68.13%-13.08M
-79.83%-50.48M
Research and development
2.23%24.74M
20.56%184.63M
-6.25%86.49M
-5.70%52.03M
25.15%24.2M
-4.91%153.15M
-2.34%92.26M
-16.66%55.17M
-33.28%19.33M
7.94%161.05M
Credit Impairment Loss
6.15%-5.93M
-833.50%-23.3M
-208.27%-16.66M
-107.88%-9.76M
37.34%-6.32M
67.15%-2.5M
76.37%-5.4M
37.93%-4.69M
-104.33%-10.08M
20.40%-7.6M
Asset Impairment Loss
-237.21%-1.45M
-28.61%-71.86M
-19.35%-17.18M
33.83%-5.91M
123.72%1.05M
-440.31%-55.87M
-13.76%-14.4M
-34.86%-8.94M
-3.54%-4.44M
-351.33%-10.34M
Other net revenue
-23.83%78.68M
5.03%234.86M
-0.41%195.28M
99.62%191.23M
197.55%103.29M
2.21%223.61M
33.46%196.08M
-14.55%95.8M
-26.48%34.71M
6.62%218.77M
Invest income
-23.11%77.9M
12.36%308.11M
5.27%219.4M
89.04%198.61M
109.82%101.32M
28.45%274.22M
27.46%208.4M
-6.08%105.06M
-2.56%48.29M
33.09%213.49M
-Including: Investment income associates
-27.54%72.6M
49.83%294.58M
60.86%211.28M
94.09%195.28M
125.57%100.2M
5.94%196.61M
-11.87%131.35M
-8.26%100.61M
-8.36%44.42M
23.20%185.6M
Asset deal income
-356.00%-171.38K
-86.22%149.29K
--149.29K
--164.01K
--66.95K
-91.20%1.08M
----
----
----
63.32%12.32M
Other revenue
15.98%8.32M
226.09%21.76M
28.08%9.58M
86.06%8.13M
655.41%7.17M
-38.79%6.67M
-1.49%7.48M
-12.64%4.37M
-19.87%949.42K
-74.44%10.9M
Operating profit
-3.04%440.78M
11.93%1.1B
13.14%961.95M
46.73%808.89M
95.40%454.6M
13.08%980.05M
12.45%850.22M
3.02%551.27M
-5.78%232.64M
10.38%866.68M
Add:Non operating Income
53.64%773.36K
5.84%3.08M
302.78%1.77M
131.34%768.66K
96.10%503.35K
-68.78%2.91M
-95.55%440.62K
-92.92%332.26K
-83.82%256.69K
161.94%9.34M
Less:Non operating expense
226.50%1.01M
69.20%4.7M
-11.02%2.44M
-48.14%925.54K
210.40%310.03K
-13.43%2.78M
33.07%2.74M
637.68%1.78M
130.14%99.88K
-84.50%3.21M
Total profit
-3.13%440.54M
11.75%1.1B
13.37%961.29M
47.09%808.74M
95.36%454.79M
12.30%980.19M
11.00%847.92M
1.90%549.82M
-6.30%232.8M
13.64%872.81M
Less:Income tax cost
0.26%57.15M
18.45%126.66M
17.26%119.26M
31.19%94.27M
86.57%57.01M
24.44%106.93M
17.02%101.71M
7.31%71.86M
-3.46%30.55M
-2.79%85.93M
Net profit
-3.62%383.38M
10.93%968.71M
12.84%842.02M
49.48%714.47M
96.68%397.78M
10.98%873.26M
10.22%746.21M
1.14%477.97M
-6.72%202.25M
15.77%786.88M
Net profit from continuing operation
-3.62%383.38M
10.93%968.71M
12.84%842.02M
49.48%714.47M
96.68%397.78M
10.98%873.26M
10.22%746.21M
1.14%477.97M
-6.72%202.25M
15.77%786.88M
Less:Minority Profit
-31.23%-3.94M
-257.03%-18M
-193.72%-16.17M
-187.41%-8.02M
-213.75%-3.01M
-35.35%11.46M
11.35%17.25M
-8.68%9.18M
-31.70%2.64M
-1.25%17.73M
Net profit of parent company owners
-3.36%387.33M
14.49%986.71M
17.73%858.19M
54.12%722.49M
100.79%400.79M
12.05%861.79M
10.20%728.96M
1.35%468.79M
-6.27%199.6M
16.24%769.14M
Earning per share
Basic earning per share
-3.85%0.5
14.29%1.28
16.84%1.11
54.10%0.94
100.00%0.52
12.00%1.12
10.47%0.95
1.67%0.61
-7.14%0.26
16.28%1
Diluted earning per share
-3.85%0.5
15.32%1.28
18.09%1.11
54.10%0.94
100.00%0.52
11.00%1.11
9.30%0.94
1.67%0.61
-7.14%0.26
16.28%1
Other composite income
-1,143.82%-1.07M
541.60%4.81M
-51.27%837.8K
231.83%1.37M
130.01%102.09K
-114.64%-1.09M
117.88%1.72M
15.17%-1.04M
-333.30%-340.14K
136.16%7.43M
Other composite income of parent company owners
-1,143.82%-1.07M
541.60%4.81M
-51.27%837.8K
231.83%1.37M
130.01%102.09K
-114.64%-1.09M
117.88%1.72M
15.17%-1.04M
-333.30%-340.14K
136.16%7.43M
Total composite income
-3.91%382.32M
11.62%973.51M
12.69%842.86M
50.09%715.84M
97.06%397.88M
9.80%872.17M
12.07%747.93M
1.18%476.93M
-6.84%201.91M
20.51%794.31M
Total composite income of parent company owners
-3.65%386.26M
15.20%991.51M
17.57%859.03M
54.76%723.86M
101.19%400.89M
10.83%860.71M
12.09%730.68M
1.39%467.75M
-6.39%199.26M
21.12%776.58M
Total composite income of minority owners
-31.23%-3.94M
-257.03%-18M
-193.72%-16.17M
-187.41%-8.02M
-213.75%-3.01M
-35.35%11.46M
11.35%17.25M
-8.68%9.18M
-31.70%2.64M
-1.25%17.73M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
CITIC Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -3.19%2.09B-0.33%8.22B4.13%5.79B8.31%4.09B14.03%2.15B19.42%8.25B3.94%5.56B3.69%3.77B3.42%1.89B4.60%6.91B
Operating revenue -3.19%2.09B-0.33%8.22B4.13%5.79B8.31%4.09B14.03%2.15B19.42%8.25B3.94%5.56B3.69%3.77B3.42%1.89B4.60%6.91B
Other operating revenue -----9.16%16.23M-----28.99%6.34M----16.58%17.87M-----0.40%8.92M----12.34%15.33M
Total operating cost -4.42%1.72B-1.77%7.36B2.39%5.03B4.56%3.47B6.61%1.8B19.70%7.49B3.50%4.91B3.17%3.32B3.95%1.69B3.92%6.26B
Operating cost -8.42%1.01B-7.09%4.6B-2.68%3.19B-2.13%2.17B-3.61%1.1B19.40%4.96B5.81%3.28B5.71%2.22B8.32%1.14B3.05%4.15B
Operating tax surcharges 7.74%22.61M3.07%79.05M0.33%53.02M4.43%40.31M19.04%20.99M19.60%76.69M9.18%52.85M11.57%38.6M6.86%17.63M10.00%64.12M
Operating expense -6.27%553.35M7.98%2.13B16.86%1.45B24.52%1.07B38.65%590.35M26.52%1.97B2.93%1.24B2.47%855.8M-1.33%425.79M6.76%1.56B
Administration expense 63.26%111.49M0.99%381.63M-5.76%254.19M-10.78%156.98M-28.54%68.29M1.25%377.89M-13.70%269.72M-12.70%175.94M-5.27%95.56M4.47%373.22M
Financial expense 116.36%688.58K60.72%-15.62M50.84%-16.13M35.45%-16.82M64.38%-4.21M12.84%-39.77M-39.97%-32.8M-30.33%-26.05M-53.51%-11.82M-70.78%-45.63M
-Interest expense (Financial expense) -15.17%6.83M249.15%35.85M626.10%27.83M975.31%17M--8.06M249.61%10.27M30.49%3.83M--1.58M----44,000.67%2.94M
-Interest Income (Financial expense) 44.03%-6.88M2.64%-54.64M-15.17%-46.03M-21.10%-35.73M6.05%-12.29M-11.18%-56.12M-50.42%-39.97M-48.75%-29.51M-68.13%-13.08M-79.83%-50.48M
Research and development 2.23%24.74M20.56%184.63M-6.25%86.49M-5.70%52.03M25.15%24.2M-4.91%153.15M-2.34%92.26M-16.66%55.17M-33.28%19.33M7.94%161.05M
Credit Impairment Loss 6.15%-5.93M-833.50%-23.3M-208.27%-16.66M-107.88%-9.76M37.34%-6.32M67.15%-2.5M76.37%-5.4M37.93%-4.69M-104.33%-10.08M20.40%-7.6M
Asset Impairment Loss -237.21%-1.45M-28.61%-71.86M-19.35%-17.18M33.83%-5.91M123.72%1.05M-440.31%-55.87M-13.76%-14.4M-34.86%-8.94M-3.54%-4.44M-351.33%-10.34M
Other net revenue -23.83%78.68M5.03%234.86M-0.41%195.28M99.62%191.23M197.55%103.29M2.21%223.61M33.46%196.08M-14.55%95.8M-26.48%34.71M6.62%218.77M
Invest income -23.11%77.9M12.36%308.11M5.27%219.4M89.04%198.61M109.82%101.32M28.45%274.22M27.46%208.4M-6.08%105.06M-2.56%48.29M33.09%213.49M
-Including: Investment income associates -27.54%72.6M49.83%294.58M60.86%211.28M94.09%195.28M125.57%100.2M5.94%196.61M-11.87%131.35M-8.26%100.61M-8.36%44.42M23.20%185.6M
Asset deal income -356.00%-171.38K-86.22%149.29K--149.29K--164.01K--66.95K-91.20%1.08M------------63.32%12.32M
Other revenue 15.98%8.32M226.09%21.76M28.08%9.58M86.06%8.13M655.41%7.17M-38.79%6.67M-1.49%7.48M-12.64%4.37M-19.87%949.42K-74.44%10.9M
Operating profit -3.04%440.78M11.93%1.1B13.14%961.95M46.73%808.89M95.40%454.6M13.08%980.05M12.45%850.22M3.02%551.27M-5.78%232.64M10.38%866.68M
Add:Non operating Income 53.64%773.36K5.84%3.08M302.78%1.77M131.34%768.66K96.10%503.35K-68.78%2.91M-95.55%440.62K-92.92%332.26K-83.82%256.69K161.94%9.34M
Less:Non operating expense 226.50%1.01M69.20%4.7M-11.02%2.44M-48.14%925.54K210.40%310.03K-13.43%2.78M33.07%2.74M637.68%1.78M130.14%99.88K-84.50%3.21M
Total profit -3.13%440.54M11.75%1.1B13.37%961.29M47.09%808.74M95.36%454.79M12.30%980.19M11.00%847.92M1.90%549.82M-6.30%232.8M13.64%872.81M
Less:Income tax cost 0.26%57.15M18.45%126.66M17.26%119.26M31.19%94.27M86.57%57.01M24.44%106.93M17.02%101.71M7.31%71.86M-3.46%30.55M-2.79%85.93M
Net profit -3.62%383.38M10.93%968.71M12.84%842.02M49.48%714.47M96.68%397.78M10.98%873.26M10.22%746.21M1.14%477.97M-6.72%202.25M15.77%786.88M
Net profit from continuing operation -3.62%383.38M10.93%968.71M12.84%842.02M49.48%714.47M96.68%397.78M10.98%873.26M10.22%746.21M1.14%477.97M-6.72%202.25M15.77%786.88M
Less:Minority Profit -31.23%-3.94M-257.03%-18M-193.72%-16.17M-187.41%-8.02M-213.75%-3.01M-35.35%11.46M11.35%17.25M-8.68%9.18M-31.70%2.64M-1.25%17.73M
Net profit of parent company owners -3.36%387.33M14.49%986.71M17.73%858.19M54.12%722.49M100.79%400.79M12.05%861.79M10.20%728.96M1.35%468.79M-6.27%199.6M16.24%769.14M
Earning per share
Basic earning per share -3.85%0.514.29%1.2816.84%1.1154.10%0.94100.00%0.5212.00%1.1210.47%0.951.67%0.61-7.14%0.2616.28%1
Diluted earning per share -3.85%0.515.32%1.2818.09%1.1154.10%0.94100.00%0.5211.00%1.119.30%0.941.67%0.61-7.14%0.2616.28%1
Other composite income -1,143.82%-1.07M541.60%4.81M-51.27%837.8K231.83%1.37M130.01%102.09K-114.64%-1.09M117.88%1.72M15.17%-1.04M-333.30%-340.14K136.16%7.43M
Other composite income of parent company owners -1,143.82%-1.07M541.60%4.81M-51.27%837.8K231.83%1.37M130.01%102.09K-114.64%-1.09M117.88%1.72M15.17%-1.04M-333.30%-340.14K136.16%7.43M
Total composite income -3.91%382.32M11.62%973.51M12.69%842.86M50.09%715.84M97.06%397.88M9.80%872.17M12.07%747.93M1.18%476.93M-6.84%201.91M20.51%794.31M
Total composite income of parent company owners -3.65%386.26M15.20%991.51M17.57%859.03M54.76%723.86M101.19%400.89M10.83%860.71M12.09%730.68M1.39%467.75M-6.39%199.26M21.12%776.58M
Total composite income of minority owners -31.23%-3.94M-257.03%-18M-193.72%-16.17M-187.41%-8.02M-213.75%-3.01M-35.35%11.46M11.35%17.25M-8.68%9.18M-31.70%2.64M-1.25%17.73M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --CITIC Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg